tradingkey.logo

KORU Medical Systems Inc

KRMD
4.920USD
+0.050+1.03%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
227.76MCap. mercado
PérdidaP/E TTM

KORU Medical Systems Inc

4.920
+0.050+1.03%

Más Datos de KORU Medical Systems Inc Compañía

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

Información de KORU Medical Systems Inc

Símbolo de cotizaciónKRMD
Nombre de la empresaKORU Medical Systems Inc
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoTharby (Linda M)
Número de empleados80
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección100 Corporate Drive
CiudadMAHWAH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07430
Teléfono18454692042
Sitio Webhttps://www.korumedical.com/
Símbolo de cotizaciónKRMD
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoTharby (Linda M)

Ejecutivos de KORU Medical Systems Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+29463.00%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
+300000.00%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
94.10K
+2581.00%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
91.47K
+2581.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
91.11K
+2581.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+26904.00%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
44.27K
+2581.00%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+29463.00%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
+300000.00%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
94.10K
+2581.00%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
91.47K
+2581.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
91.11K
+2581.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+26904.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Domestic Core
6.12M
58.86%
International Core
3.70M
35.53%
Novel Therapies
584.27K
5.62%
Por regiónUSD
Nombre
Ganancia
Proporción
Domestic
6.71M
64.47%
International
3.70M
35.53%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Domestic Core
6.12M
58.86%
International Core
3.70M
35.53%
Novel Therapies
584.27K
5.62%

Estadísticas de accionistas

Actualizado: jue., 5 de feb
Actualizado: jue., 5 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.77%
Tharby (Linda M)
4.58%
Otro
60.33%
Accionistas
Accionistas
Proporción
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.77%
Tharby (Linda M)
4.58%
Otro
60.33%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
22.17%
Investment Advisor
17.32%
Investment Advisor/Hedge Fund
16.24%
Individual Investor
8.54%
Pension Fund
0.84%
Research Firm
0.33%
Bank and Trust
0.10%
Insurance Company
0.01%
Otro
34.45%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
179
26.41M
57.01%
-1.20M
2025Q3
175
25.43M
54.99%
-237.14K
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Horton Capital Management LLC
5.87M
12.68%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.53M
9.77%
-153.89K
-3.29%
Sep 30, 2025
Topline Capital Management, LLC
3.65M
7.88%
+39.89K
+1.11%
Sep 30, 2025
The Vanguard Group, Inc.
2.15M
4.63%
+60.11K
+2.88%
Sep 30, 2025
Tharby (Linda M)
2.12M
4.58%
+29.46K
+1.41%
Oct 16, 2025
BlackRock Institutional Trust Company, N.A.
1.93M
4.17%
+266.62K
+16.00%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.01M
2.17%
+9.65K
+0.97%
Sep 30, 2025
Meros Investment Management, LP
848.90K
1.83%
-1.49K
-0.18%
Sep 30, 2025
Empire Financial Management Company, LLC
824.53K
1.78%
+824.53K
--
Sep 30, 2025
Archon Capital Management LLC
700.15K
1.51%
--
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Ver más
iShares Micro-Cap ETF
Proporción0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.03%
iShares Russell 2000 ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI